Cancer Therapy Assessment Accounting for Heterogeneity Using q-Rung Picture Fuzzy Dynamic Aggregation Approach

Due to the fact that there is no symmetry in the division of cancer cells, it is important to consider this asymmetrical behavior. Because of this heterogeneity during any therapy, not every cancer cell that is killed only is abolished, which is sensitive to the particular treatment chosen. Mathemat...

Full description

Bibliographic Details
Main Authors: Rukhsana Kausar, Hafiz Muhammad Athar Farid, Muhammad Riaz, Darko Božanić
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Symmetry
Subjects:
Online Access:https://www.mdpi.com/2073-8994/14/12/2538
Description
Summary:Due to the fact that there is no symmetry in the division of cancer cells, it is important to consider this asymmetrical behavior. Because of this heterogeneity during any therapy, not every cancer cell that is killed only is abolished, which is sensitive to the particular treatment chosen. Mathematical models that describe these pathways are critical for predicting cancer cell proliferation behavior. The literature on the mathematical modeling of cancer onset, growth, and metastasis is extensive. Both deterministic and stochastic factors were used to develop mathematical models to mimic the development rate of cancer cells. We focus on the cell’s heterogeneity in our model so that the cells generally responsible for spreading cancer, which are called stem cells, can be killed. Aggregation operators (AOs) play an important role in decision making, especially when there are several competing factors. A key issue in the case of uncertain data is to develop appropriate solutions for the aggregation process. We presented two novel Einstein AOs: q-rung picture fuzzy dynamic Einstein weighted averaging (q-RPFDEWA) operator and q-rung picture fuzzy dynamic Einstein weighted geometric (q-RPFDEWG) operator. Several enticing aspects of these AOs are thoroughly discussed. Furthermore, we provide a method for dealing with multi-period decision-making (MPDM) issues by applying optimal solutions. A numerical example is presented to explain how the recommended technique can be used in cancer therapy assessment. Authenticity analysis is also presented to demonstrate the efficacy of the proposed technique. The suggested AOs and decision-making methodologies are generally applicable in real-world multi-stage and dynamic decision analysis.
ISSN:2073-8994